SF3A3 Promotes Hepatocellular Carcinoma Progression and Regulates Jagged 2–Notch 1 Signaling

ABSTRACT Splicing factor 3a subunit 3 (SF3A3) has been reported to be dysregulated in various cancers. Previous studies have suggested its prognostic value in hepatocellular carcinoma (HCC), but the specific effect and molecular mechanisms remain to be further explored. Therefore, this study aims to investigate the role of SF3A3 in HCC pathogenesis. SF3A3 expression was compared between HCC and normal tissues using public databases and immunohistochemistry, and its clinical significance was evaluated by clinicopathological, ROC, and Kaplan–Meier analyses. Differential expression and enrichment analyses explored potential biological functions. In vitro assays assessed the effects of SF3A3 knockdown on HCC cell proliferation, migration, and invasion. RNA sequencing, molecular validation, and rescue experiments investigated the underlying mechanism, while a nude mouse xenograft model evaluated its role in vivo. SF3A3 was significantly upregulated in HCC and was associated with adverse clinicopathological features. SF3A3 expression showed discriminatory ability between HCC and normal liver tissues in retrospective transcriptomic cohorts and was associated with poor survival. Functional enrichment analyses linked SF3A3 to cell cycle regulation and DNA replication, while SF3A3 knockdown suppressed HCC cell proliferation, migration, and invasion in vitro. Transcriptomic profiling further identified Notch signaling as a potential downstream pathway, and this association was supported by rescue experiments. In conclusion, SF3A3 promotes tumor progression and is associated with regulation of Jagged 2–Notch 1 signaling. These findings provide preliminary insight into the molecular mechanisms underlying SF3A3‐mediated HCC progression and support further investigation of its potential clinical and therapeutic relevance.

Authors

Institutions

Publication Details

Journal
Molecular Carcinogenesis
Published
2026-11-15
DOI
https://doi.org/10.1002/mc.70204
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

SF3A3 Promotes Hepatocellular Carcinoma Progression and Regulates Jagged 2–Notch 1 Signaling

周光文, Luyang Liu, Jing Yang, Yan Zhang
Molecular Carcinogenesis
Hepatocellular Carcinoma Treatment and Prognosis
article

SF3A3 Promotes Hepatocellular Carcinoma Progression and Regulates Jagged 2–Notch 1 Signaling

周光文, Luyang Liu, Jing Yang, Yan Zhang
article en

Abstract

ABSTRACT Splicing factor 3a subunit 3 (SF3A3) has been reported to be dysregulated in various cancers. Previous studies have suggested its prognostic value in hepatocellular carcinoma (HCC), but the specific effect and molecular mechanisms remain to be further explored. Therefore, this study aims to investigate the role of SF3A3 in HCC pathogenesis. SF3A3 expression was compared between HCC and normal tissues using public databases and immunohistochemistry, and its clinical significance was evaluated by clinicopathological, ROC, and Kaplan–Meier analyses. Differential expression and enrichment analyses explored potential biological functions. In vitro assays assessed the effects of SF3A3 knockdown on HCC cell proliferation, migration, and invasion. RNA sequencing, molecular validation, and rescue experiments investigated the underlying mechanism, while a nude mouse xenograft model evaluated its role in vivo. SF3A3 was significantly upregulated in HCC and was associated with adverse clinicopathological features. SF3A3 expression showed discriminatory ability between HCC and normal liver tissues in retrospective transcriptomic cohorts and was associated with poor survival. Functional enrichment analyses linked SF3A3 to cell cycle regulation and DNA replication, while SF3A3 knockdown suppressed HCC cell proliferation, migration, and invasion in vitro. Transcriptomic profiling further identified Notch signaling as a potential downstream pathway, and this association was supported by rescue experiments. In conclusion, SF3A3 promotes tumor progression and is associated with regulation of Jagged 2–Notch 1 signaling. These findings provide preliminary insight into the molecular mechanisms underlying SF3A3‐mediated HCC progression and support further investigation of its potential clinical and therapeutic relevance.

Molecular Carcinogenesis
Shanghai Jiao Tong University (CN), Heidelberg University (DE), University Hospital Heidelberg (DE), Shanghai Sixth People's Hospital (CN), Chirurgische Universitätsklinik Heidelberg (DE)
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon